The Molnupiravir Capsules, cataloged under National Stock Number 6505-01-714-9242, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Merck Sharp & Dohme Llc. Government technical data includes 2 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-714-9242 |
| Primary Part Number | NDC00006-5055-06 |
| Item Name | Molnupiravir Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Merck Sharp & Dohme Llc |
| Status | ACTIVE |
| Unit of Issue Cube | 0.0046 CUBIC FEET |
| Unpackaged Unit Weight | 0.1433 POUNDS LBS |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00006-5055-06 PRIMARY | Merck Sharp & Dohme Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM239409 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1658187 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-714-9242 is a Molnupiravir Capsules, manufactured by Merck Sharp & Dohme Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-714-9242 has 1 manufacturer part number on file: NDC00006-5055-06 (Merck Sharp & Dohme Llc).
Key specifications for NDC00006-5055-06: Unit of Issue Cube: 0.0046 CUBIC FEET; Special Features: INDICATED FOR THE TREATMENT COVID; MECHANISM OF ACTION: INHIBITS REPLICATION BY VIRAL MUTAGENESIS FOR THE TREATMENT OF MILD TO MODERATE CORONAVIRUS DISEASE WHO ARE AT A HIGH RISK FOR PROGRESSION TO SEVERE COVID; PACKAGED AS 200 MG CAPSULES; INTENDED FOR ORAL ADMINISTRATION; 40 CAPSULES PER BOTTLE; STORE AT 20C TO 25C(68F TO 77F); EXCURSIONS PERMITTED BETWEEN 15C TO 30C(59F TO 86F)(SEE USP CONTROLLED ROOM TEMPERATURE); FOR USE UNDER EMERGENCY USE AUTHORIZATION(EUA); SHELF LIFE: 24 MONTHS.; Part Name Assigned by Controlling Agency: MOLNUPIRAVIR CAPSULES, 200MG, 40S; Unpackaged Unit Weight: 0.1433 POUNDS LBS. 2 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.